Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04065347 · ClinicalTrials.gov registry record
Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 84
- Enrollment target
NCT04065347 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 84 participants.
The verdict
NCT04065347 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
This study is being done to evaluate the relationship between adherence to antiretroviral therapy (ART) and HIV drug concentrations in persons living with HIV (PLWH) that are taking tenofovir alafenamide (TAF). Adherence will be measured with an ingestible biosensor (digital pill). Antiretroviral drug concentrations will be measured in different types of blood cells.
Interventions
- DEVICE Digital Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2019-11-21 |
| Est. Completion | 2023-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04065347
The ClinicalTrials.gov registry entry for NCT04065347 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital Pill is the first listed.
NCT04065347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04065347 about?
NCT04065347 is a clinical study titled "Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)". This study is being done to evaluate the relationship between adherence to antiretroviral therapy (ART) and HIV drug concentrations in persons living with HIV (PLWH) that are taking tenofovir alafenamide (TAF). Adherence will be measured with an ingestible biosensor (digital pill). Antiretroviral dr...
What is the current status of trial NCT04065347?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2019-11-21. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT04065347?
The interventions under investigation include: Digital Pill (DEVICE).
Who is sponsoring clinical trial NCT04065347?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.